|
ZNF274 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.981600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.122200E-01 |
| Normal-vs-Stage2 |
9.129000E-01 |
| Normal-vs-Stage3 |
1.661040E-03 |
| Normal-vs-Stage4 |
6.362800E-03 |
| Stage1-vs-Stage2 |
8.427000E-01 |
| Stage1-vs-Stage3 |
2.940100E-03 |
| Stage1-vs-Stage4 |
3.859700E-02 |
| Stage2-vs-Stage3 |
1.596160E-01 |
| Stage2-vs-Stage4 |
1.682050E-01 |
| Stage3-vs-Stage4 |
8.550000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.263600E-01 |
| Normal-vs-AfricanAmerican |
6.599800E-01 |
| Normal-vs-Asian |
7.567600E-02 |
| Caucasian-vs-AfricanAmerican |
5.580000E-01 |
| Caucasian-vs-Asian |
2.938000E-01 |
| AfricanAmerican-vs-Asian |
2.902800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.888200E-01 |
| Normal-vs-Female |
6.631200E-01 |
| Male-vs-Female |
4.432400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.262200E-01 |
| Normal-vs-Extreme_Weight |
9.837800E-01 |
| Normal-vs-Obese |
3.136200E-01 |
| Normal-vs-Extreme_Obese |
1.603220E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.307600E-01 |
| Normal_Weight-vs-Obese |
7.134100E-02 |
| Normal_Weight-vs-Extreme_Obese |
8.813600E-01 |
| Extreme_Weight-vs-Obese |
3.114400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.663200E-01 |
| Obese-vs-Extreme_Obese |
7.978300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.082800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.300800E-01 |
| Normal-vs-Age(61-80Yrs) |
7.645400E-01 |
| Normal-vs-Age(81-100Yrs) |
5.138800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.771000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.524000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.311800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.661600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.975000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.592600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.366400E-02 |
| Normal-VS-Type2 PRCC |
8.375900E-04 |
| Normal-VS-KIRP CIMP |
3.646400E-01 |
| Normal-VS-Unclassified PRCC |
3.785400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.64199995004111E-09 |
| Type1 PRCC-VS-KIRP CIMP |
7.632100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.904010E-02 |
| Type2 PRCC-VS-KIRP CIMP |
5.927600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.092190E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.916800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.841500E-02 |
| Normal-vs-N1 |
1.942820E-01 |
| Normal-vs-N2 |
5.620000E-04 |
| N0-vs-N1 |
6.668200E-01 |
| N0-vs-N2 |
1.275780E-01 |
| N1-vs-N2 |
1.117000E-01 |
|
|
